Cargando…
PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428968/ http://dx.doi.org/10.1097/01.HS9.0000851060.08910.17 |
_version_ | 1784779285453602816 |
---|---|
author | Perolla, A. Pulluqi, P. Cili, A. Calliku, E. Caja, T. Ivanaj, A. |
author_facet | Perolla, A. Pulluqi, P. Cili, A. Calliku, E. Caja, T. Ivanaj, A. |
author_sort | Perolla, A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9428968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94289682022-08-31 PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION Perolla, A. Pulluqi, P. Cili, A. Calliku, E. Caja, T. Ivanaj, A. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428968/ http://dx.doi.org/10.1097/01.HS9.0000851060.08910.17 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Perolla, A. Pulluqi, P. Cili, A. Calliku, E. Caja, T. Ivanaj, A. PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION |
title | PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION |
title_full | PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION |
title_fullStr | PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION |
title_full_unstemmed | PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION |
title_short | PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION |
title_sort | pb2057: real -world overall survival of myelofibrosis patients on ruxolitinib – a 6 year analysis in albanian population |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428968/ http://dx.doi.org/10.1097/01.HS9.0000851060.08910.17 |
work_keys_str_mv | AT perollaa pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation AT pulluqip pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation AT cilia pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation AT callikue pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation AT cajat pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation AT ivanaja pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation |